Trusted by more than 150 enterprises and funds, helping raise over £450m
Since 2008, we've helped more high impact enterprises and funds with seed through series B style transactions than any other firm in Europe.Our track record
Recent News & Announcements
ClearlySo in the Financial Times: Milk alternative Oatly on a quest to become a $10bn brand
Adding further comment to the alt-protein and alt-dairy conversation, David Gowenlock offers additional comment on plant-based alternatives in the investment space, in this latest article.
ClearlySo in the Financial Times: Funding boom for faux meat and dairy start-ups
David Gowenlock, Fund Advisory at ClearlySo weighs in on the rise in capital towards alt-protein based initiatives in this article by the FT.
ClearlySo client TenX Health joins Octopus Ventures in major boost to its digital healthcare revolution
Octopus to cornerstone proposed £100m institutional global fund to take advantage of the health technology market opportunity